Neuroblastoma.
This record summarizes neuroblastoma's variable clinical risk, common adrenal origin, risk-adapted treatment, and the role of surgical resection in local control.
Open original publication →What the AI sees
This record summarizes neuroblastoma's variable clinical risk, common adrenal origin, risk-adapted treatment, and the role of surgical resection in local control.
Research significance
The supplied abstract supports risk-based treatment intensity and surgery as established management concepts; it can only be inferred, not demonstrated here, that further refinement of risk selection or surgical strategy could improve outcomes or reduce treatment burden.
Source abstract
Neuroblastoma (NB) is the most common extracranial pediatric solid tumor. The most common location for development of NB is in the adrenal glands, but primary tumors may develop along the developmental pathway of neural crest progenitor cells. NB may vary in severity and prognosis from low-risk congenital neuroblastic lesions to aggressive high-risk neuroblastoma. Therapy is risk-based with intensification of therapy for those at greater risk and de-escalation for patients with lower risk tumors. Surgical resection has a critical role in local control of NB for the most optimal outcome.